USPTO serial 79306239
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas D. Bratschun
Thomas D. Bratschun Adsero IP8210 Southpark TerraceLittleton, CO 80120UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific and research purposes | ACTIVE | — |
| 005 | Pharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of neurological diseases and disorders; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapy, including t cell therapy | ACTIVE | — |
| 044 | Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; counselling and charitable services for patients, namely, providing medical information and assistance with respect to obtaining prescription medications; medical consultation, namely, providing advice to healthcare professionals regarding medical disorders and their diagnosis, prevention and treatment; providing medical information; providing medical information regarding treatment, prevention, and diagnosis of medical conditions; medical information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the Internet | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 14, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 14, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 16, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 14, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 21, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |